A Targeted Approach to HealthCare
Bayer HealthCare Pharmaceuticals' goal is to discover products that will improve human health worldwide by diagnosing, preventing and treating diseases. As a specialty pharmaceutical company, we focus our efforts where we can have the most impact.
For more than 100 years, Bayer has been dedicated to developing, manufacturing and marketing pharmaceuticals. Built on the company's long history of providing medicines that healthcare providers and patients can trust, Bayer is one of the most recognized brands in health care.
Bayer News Releases
23 July 2008 - Bayer News Releases The New England Journal of Medicine Publishes Nexavar® Study Demonstrating Significant Improvement in Overall Survival in Patients with Liver Cancer more
8 July 2008 - Bayer News Releases FDA Approves EOVIST® to Detect and Characterize Focal Liver Lesions more
2 July 2008 - Bayer News Releases Bayer HealthCare acquires hematology development portfolio featuring MAXY-VII from Maxygen more
24 June 2008 - Bayer News Releases Bayer concludes supply and licensing agreements for Yasmin® and YAZ® with Barr for the United States more
5 June 2008 - Bayer News Releases Study Supports Possible Use of Leukine(R) as a Potential Adjuvant Therapy for High-Risk Melanoma Patients more
Further Information
Important Trasylol® Safety Information
New - Important Information for Health ProfessionalsClinical Trials
Information about clinical studies is available in the Bayer HealthCare database as well as at clinicaltrials.govand clinicalstudyresults.org.
Bayer Reports Findings of Trasylol Independent Investigation
Press StatementInvestigator Report
Key Committees - Bayer Global Drug Safety